Articles tagged with Personalized Medicine
ComboMATCH initiates patient enrollment to test new cancer drug combinations guided by tumor biology, exploring precision medicine and targeting proteins that control cancer growth. The project aims to identify beneficial therapies for patients with rare malignancies and/or rare molecular abnormalities.
A Vanderbilt study found that enhanced treatment support doubles the odds of quitting among fast nicotine metabolizers. Providing personalized coaching on nicotine replacement therapy reduces the abstinence disparity with slow metabolizers.
The PARIS Test, a CLIA-certified drug sensitivity assay, uses patient-derived tumor organoids to screen an array of drugs and develop personalized treatment reports. Ibrutinib, a BTK inhibitor approved only for certain leukemias and lymphomas, was identified as the optimal treatment for a patient with ovarian cancer.
The National Institutes of Health is enrolling 10,000 participants in a landmark precision nutrition study. The study aims to develop algorithms predicting how individuals respond to different foods and diets based on genetic, lifestyle, and environmental factors.
Researchers developed a biobank of head and neck cancer organoids to validate biomarkers and predict treatment responses. The study found that organoid responses matched patient outcomes, suggesting potential for personalized therapies.
A UNLV study found a significant correlation between 10 specific types of gut bacteria and the likelihood of developing Alzheimer's disease, with certain bacteria identified as protective or risk factors. The findings suggest that an imbalance of gut microbiota may play a role in the disorder's development.
Physicians are urging primary care teams to use data-driven approaches to prevent and mitigate climate-related health issues, dubbed "precision ecologic medicine". This approach combines patient-specific data with climate-related information to predict and support vulnerable patients.
A new study published in JCI Insight identified a second target for treating depression using transcranial magnetic stimulation (TMS), showing that each target alleviates a different set of symptoms. Patients who had high baseline depression and anxiety measures responded better to standard TMS treatment, while those with low baseline ...
A study by UMC Utrecht shows that corona patients can measure their blood oxygen levels at home using a pulse oximeter, feeling safe and experiencing more control. This method does not increase GP visits or hospitalization but contributes to relieving caregivers and keeping healthcare affordable.
NUTRITION 2023 will cover the latest developments in nutrition science, with over 1,800 original research studies submitted for presentation. The event brings together nutritional professionals from around the globe to discuss key topics such as sustainable diets and their impact on health.
Scientists have developed a new method to deliver genetic information to stem cells using nanoparticles coated with a specific polymer, enabling more efficient control over cellular differentiation. This innovation has the potential to improve the efficiency and effectiveness of regenerative medicine treatments.
A comprehensive care plan has been published to prevent preeclampsia, a leading cause of pregnancy-related death in the US. The plan provides specific recommendations for both expecting parents and clinicians, including daily low-dose aspirin, surveillance, and behavioral strategies.
A new 'enhanced primary care' model has been found to be effective in reducing blood pressure and hemoglobin A1c levels among patients with severe mental illness. The study, conducted at UNC WakeBrook, showed significant improvements in screening for people with severe mental illness compared to usual primary care.
A team of Lithuanian scientists created a VR-based rehabilitation system to help patients recover from stroke. The system uses sensors to track the patient's movements and provides real-time feedback to improve motor function, balance, and coordination.
Researchers at TUM have developed a method to create mini-hearts in Petri dishes using stem cells. The resulting organoids mimic the earliest stages of human heart development and can be used to investigate congenital heart defects, potentially leading to new treatment methods.
The Human Brain Project has achieved significant scientific breakthroughs, including world-leading 3D brain atlases and personalized medicine based on computational modeling. The project's legacy will leave a lasting impact on the research community.
Researchers have created a new tool, EN-TEx, to analyze genetic mutations and predict disease risk. The catalog of allele-specific variants provides rich data for accurate personal genomics, enabling scientists to study the effects of genetic mutations in tissues that are difficult to obtain without surgery.
A real-world analysis found that high-risk Americans who fail to reach guideline-recommended LDL-C levels experience a 44% higher rate of cardiovascular events. The study, presented at the AMCP Conference, used data from over 300 million Americans and compared those who met and maintained recommended targets with those who did not.
A systematic review of 156 trials found that physical exercise improved motor symptoms and quality of life in people with Parkinson's Disease. Most types of structured exercise, including dance, water-based exercise, and endurance training, showed clinically meaningful benefits.
A recent study found that the side effects of treating brain diseases with antisense oligonucleotides are related to altered calcium balance. By modulating calcium levels, researchers hope to reduce neurotoxicity and improve treatment outcomes for various neurological diseases.
The HALP score, a novel immune-nutritional marker, has been linked to prognostic ability in different cancer types. It integrates indicators of immune status and nutritional status, showing promise as a cost-effective biomarker.
A recent study found that promoting physical activity and behavioral support can help smokers reduce their smoking in the short-term, but delivering lasting benefits is challenging. The research, which recruited over 900 smokers, discovered that engaging with motivational support had some initial benefits, but only a small percentage o...
A study published in the American Journal of Critical Care found that a single trained observer serving as a checklist prompter can accurately assess whether multidisciplinary rounds addressed key elements of the ABCDEF bundle. This approach enables customized, shorter checklists to streamline workflows and improve patient care.
The ESMO Targeted Anticancer Therapies Congress 2023 features presentations on drug discovery and development for various targets, precision medicine, and early clinical trial methodology. Keynote lectures highlight novel insights in mutational signatures and epigenetic therapies.
Researchers at the University of Missouri have designed a soft and breathable material that can be worn on the skin without causing discomfort. The material, made from liquid-metal elastomer composite, has integrated antibacterial and antiviral properties to prevent the formation of harmful pathogens.
Dr. Ruth Ann Marrie has made significant contributions to multiple sclerosis research, including the discovery of comorbidities' impact on MS evolution and development of personalized medicine strategies. Her work aims to improve quality of life by stopping and preventing MS through early intervention and targeted treatments.
Researchers from the University of Tsukuba found that web-based interventions are effective in promoting weight loss in people with overweight and obesity. The most effective components include social support, self-monitoring, behavioral goal setting, and personalized information.
Researchers investigate how lung cancers evade the immune system to develop more effective immunotherapy treatments. The study aims to uncover a new way lung cancers disguise themselves from the immune system, potentially leading to improved treatment outcomes.
The updated guidelines aim to increase impact and improve research integrity by defining and measuring outcomes in clinical trials. The new extensions include nine outcome-specific items that should be defined in all trial protocols and 17 additional items to address in published reports, ensuring transparency and relevance for patients.
Researchers identified two molecularly distinct subsets of long COVID symptoms with opposing gene expression patterns during acute COVID-19. These findings suggest multiple independent processes leading to different long COVID symptoms, which are already present during the acute infection.
Researchers at the University of Missouri are developing a wearable heart monitor using a breathable material with antibacterial and antiviral properties. The device will track heart health via dual signals, providing continuous monitoring for early detection of heart disease.
Researchers have discovered that a specific mutation in the misfolding protein causing Parkinson's disease can also protect against multiple system atrophy (MSA), another fatal neurodegenerative disorder. The findings provide a promising lead for developing targeted treatments using personalized medicine approaches.
Patients who received treatment in Spanish were twice as likely to be abstinent at six months compared to those treated in English. Receipt of nicotine replacement therapy increased abstinence rates for all patients, regardless of language preference.
Research emphasizes the importance of ethnically diverse prostate cancer genomics data and accessible genetic testing. Variations in genomic landscape of prostate cancer were observed in Chinese men compared to Western cohorts, with lower mutation rates in driver genes such as TP53 and PTEN.
The ESMO Asia Congress 2022 will focus on the latest scientific and clinical advances in oncology, with a special emphasis on the Asia-Pacific region. Media representatives can register for coverage through the official media registration form.
A new guideline aims to standardize human genomic sequencing research in Canada by establishing essential core consent elements. This will enable researchers to collect patient data in a consistent manner, ensuring transparency for participants and streamlining the review process.
Researchers from the University of Zurich have discovered why a stem cell transplant is effective in treating multiple sclerosis. The study found that memory T cells reappear immediately after the transplant and do not trigger an autoimmune reaction due to pre-damage caused by chemotherapy. This knowledge enables the body to gradually ...
ISB researchers found that the gut microbiome is responsible for variation in circulating blood metabolites across people. The study examined 930 blood metabolites and found that over 60% were associated with either host genetics or the gut microbiome.
The NCI-MATCH precision medicine cancer trial found a promising signal for the AKT inhibitor ipatasertib, meeting its primary endpoint with a 22% response rate in patients with rare AKT1 E17K tumor gene mutations. The study demonstrated clinically significant activity in patients, warranting additional studies.
Researchers found that male mice were three times more likely to survive E. coli infection due to sex-biased lipid metabolism, which may hold risks for males in today's high-calorie environment. The study identified a signaling pathway regulating lipids and growth hormone as potential therapeutic targets for fatty liver disease.
A meta-analysis by Goethe University Frankfurt found that individualized treatment combined with cognitive behavioral therapy (CBT) led to a significant increase in pain relief. The study showed an 84% higher success rate compared to standard exercise therapies, making this approach the most effective.
A new AI model called CODE-AE can accurately predict the efficacy of novel drug compounds in humans, addressing a major challenge in drug discovery. The technique has been shown to improve accuracy and robustness over state-of-the-art methods, with potential applications in personalized medicine.
New research from the University of Kansas found that two common federal survey question sets are missing significant numbers of individuals with psychiatric disabilities and chronic health conditions. The study suggests that these gaps indicate undercounting of disability funds, services, and healthcare resources.
A national US kidney disease registry found that 60% of participants were unaware of their kidney function level, hindering clinical trial recruitment. The National Kidney Foundation Patient Network aims to address this issue through real-world data collection and patient-centered research.
Research institutes from Finland, Germany, Norway, Spain, and Sweden have launched the Federated European Genome-phenome Archive (Federated EGA) to improve data sharing across national borders. The new platform enables secure access to sensitive human data for research while respecting national data protection regulations.
Researchers are using in vitro skeletal muscle models to study Type 2 diabetes and its treatment. These models enable the exploration of disease characteristics and discovery of new medicines tailored to individual patients' muscles.
A phase 3 study shows that tumour-infiltrating lymphocytes (TIL) therapy significantly improves progression-free survival compared to standard immunotherapy in patients with advanced melanoma. The treatment reduces disease progression or death by 50% in patients treated with TILs.
The DeFi trial shows targeting the Notch pathway with nirogacestat improves progression-free survival and reduces symptoms in patients with desmoid tumours. Patients reported a statistically significant benefit in reduced pain, symptom burden, and improved quality of life.
A new randomized, controlled trial demonstrates that Medasense's NOL monitoring during major abdominal surgery can reduce postoperative pain by 30% compared to standard care. The study found that personalized fentanyl dosing with NOL guidance leads to lower sympathetic activation and surgical stress, resulting in reduced PACU pain scores.
A study published in The Lancet reveals that AI-based risk profiling can improve treatment outcomes for women with heart attacks. By accounting for sex-related differences, the novel score refines current risk models and reduces mortality rates among female patients.
The webinar discusses the development of formal and community-based standards for predictive computational models in personalized medicine. Topics include ISO-Technical Specifications and collaborative research for optimizing health-related data use. A live Q&A session will also be held, providing real-time guidance for participants.
A national study by UC San Francisco found that basic home blood pressure cuffs and smartphone-connected devices have no significant difference in improving blood pressure control. After six months, patients who used basic cuffs had a lower blood pressure reduction compared to those using Bluetooth-enabled devices.
Scientists at Okayama University designed and tested a modified cholera toxin to study glycosylation in eukaryotic cells. They tracked the toxin's movement through organelles using bioluminescence, gaining insights into protein modification. This method may lead to new treatments for diseases caused by enzyme deficiencies.
Researchers used C. elegans to investigate inter-individual variation in metabolism and found genetic variants that affect metabolic differences between individuals. They discovered unique metabolites in different strains of the worm, which could help tailor biomedical recommendations to individual metabolism.
A team of researchers developed a model system to study individual differences in metabolism using C. elegans worms. They identified a novel metabolic condition linked to variation in the hphd-1 gene, which has implications for personalized medicine and tailoring dietary advice and disease treatment to an individual's genome sequence.
A new study published in PNAS found that physicians prescribe less pain medication during night shifts than during the day. Researchers attribute this discrepancy to reduced empathy among doctors on night shifts. The study analyzed data from 13,482 discharge letters and found a significant bias towards prescribing fewer painkillers at ...
University of Missouri researchers develop wearable smart bioelectronic devices, including a 'smart' face mask that can monitor physiological status and detect respiratory problems. The masks also use laser-assisted fabrication to provide breathable soft electronics for better real-time health monitoring.
A new study led by UCSF found that routine screening for and removal of precancerous anal lesions can significantly reduce the risk of anal cancer. The study, known as ANCHOR Study, showed a 57% reduction in anal cancer among people with HIV who underwent treatment for high-grade squamous intraepithelial lesions (HSIL).
A new study published in JAMA found that digital breast tomosynthesis (DBT) may reduce the chance of an advanced cancer diagnosis for women with the densest breasts and highest risk, but not all women. DBT had additional advantages for women with specific risk profiles, including a higher rate of detection of small invasive breast canc...
The JNM Molecular Imaging of Neurodegeneration Supplement provides an overview of molecular imaging techniques in neurodegenerative disorders. The supplement aims to improve early and differential diagnosis, as well as stratify and monitor therapy in these disorders.